RH

RH is a genuine turnaround in motion, not a broken business. After revenue troughed at $3.03B in FY2024, it has rebuilt to $3.44B (+8.1% YoY), operating income climbed +20.1% to $387M (11.3% margin), and diluted EPS jumped +74.3% to $6.31. The standout is cash generation: operating cash flow surged to $452M against just $200M of capex, leaving roughly $250M of free cash flow — a far healthier picture than the 3.6% net margin alone suggests. Demand is recovering and management's adjusted EBITDA of $545M shows the underlying engine is intact.

The problem is the balance sheet, and it is the whole story. Stockholders' equity is a sliver of $60.6M against $4.78B of liabilities — 78.8x leverage — and retained earnings are a negative $386M from years of buybacks executed at far higher prices. The headline 205.9% ROE is an artifact of that near-zero equity base, not a sign of quality. Most telling, the MD&A reconciliation shows net interest expense of $225M, which consumes well over half of the $387M in operating income; the $47M tax bill and that interest are what grind a respectable operating result down to $125M of net income. On an enterprise-value basis (market cap $3.07B plus substantial implied debt), the stock is meaningfully more expensive than its 25.9x P/E or 0.9x P/S imply.